(b) the end result of the session with stakeholders, such as academia and the chemical and pharmaceutical industries to ensure that any proposed laws will not deliver unintended obstacles to investigation or legitimate industrial actionIt's important to grasp that often multiple drugs or chemical compounds are frequently located in the same product